This insight into the SMURF2-GSTP1 interaction adds a crucial layer to our understanding of ferroptosis regulation, presenting SMURF2 as a key facilitator of this iron-dependent form of cell death, which could be leveraged to enhance the efficacy of pro-ferroptosis cancer therapies. Here, SMURF2 is linked to cancer.